| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000027336 |
| Receipt No. | R000031324 |
| Official scientific title of the study | Clinical evaluations of autologous fibrin glue and polyglycolic acid sheets as preventing esophageal stricture after endoscopic submucosal dissection of superficial esophageal neoplasms |
| Date of disclosure of the study information | 2017/05/15 |
| Last modified on | 2017/05/14 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Clinical evaluations of autologous fibrin glue and polyglycolic acid sheets as preventing esophageal stricture after endoscopic submucosal dissection of superficial esophageal neoplasms | |
| Title of the study (Brief title) | The efficacy of shielding method with autologous fibrin glue and polyglycolic acid sheets for the prevention of postoperative stricture after esophageal endoscopic submucosal dissection | |
| Region |
|
|
| Condition | ||
| Condition | superficial esophageal neoplasms | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The aim of this study is to clarify the safety and efficacy of shielding method with autologous fibrin glue and polyglycolic acid sheets after esophageal endoscopic submucosal dissection. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The incidence of postoperative esophageal stricture (within 26 weeks after ESD) |
| Key secondary outcomes | The number of sessions of endoscopic balloon dilatation required to resolve any strictures, and the interval between ESD and developing the regenerating epithelium. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||||
| No. of arms | 1 | |||
| Purpose of intervention | Treatment | |||
| Type of intervention |
|
|||
| Interventions/Control_1 | shielding with autologous fibrin glue and polyglycolic acid sheets | |||
| Interventions/Control_2 | ||||
| Interventions/Control_3 | ||||
| Interventions/Control_4 | ||||
| Interventions/Control_5 | ||||
| Interventions/Control_6 | ||||
| Interventions/Control_7 | ||||
| Interventions/Control_8 | ||||
| Interventions/Control_9 | ||||
| Interventions/Control_10 | ||||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. The patient must be greater than 20 years old.
2. Superficial esophageal squamous cell carcinoma or high grade intraepithelial neoplasia is diagnosed pathologically. 3. The patient is supposed to undergo ESD in our institute. 4. The mucosal defect is supposed to be more than the half circumference of esophagus. |
|||
| Key exclusion criteria | 1. The mucosal defect is supposed to be entire circumference of esophagus.
2. The lesion is supposed to be SM or deeper. 3. The level of Hb is under 11. 4. The performance is poor and it is difficult to undergo ESD. 5. Severe cardiac disease (Aortic stenosis, etc) 6. The patient has a history of fever, diarrhea, or dental extraction within 72 hours. 7. Others |
|||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | Toshiro Iizuka |
| Organization | Toranomon Hospital |
| Division name | Department of Gastroenterology |
| Address | 2-2-2 Toranomon Minato-ku Tokyo |
| TEL | 03-3588-1111 |
| t-iizuka@toranomon.gr.jp | |
| Public contact | |
| Name of contact person | Toshiro Iizuka |
| Organization | Toranomon Hospital |
| Division name | Department of Gastroenterology |
| Address | 2-2-2 Toranomon Minato-ku Tokyo |
| TEL | 03-3588-1111 |
| Homepage URL | |
| t-iizuka@toranomon.gr.jp | |
| Sponsor | |
| Institute | Toranomon Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031324 |